Manitoba Health Spending Much Higher than Average (FC014)

Manitoba continues to spend the most per capita on healthcare of the Canadian provinces, except Newfoundland Labrador.
Published on March 28, 2004

SUMMARY:

Manitoba continues to spend the most per capita on healthcare of the Canadian provinces, except Newfoundland Labrador.OBSERVATIONS:

  • The Manitoba government spends 12.0% more per capita on health care than the Canadian average. If per capita spending was at the Canadian average, it would spend about $391 million less than it presently does.
  • Manitoba spends 7.6% more per capita on health care than Saskatchewan and 6.8% more than Alberta. Although Alberta’s population is younger on average, no demographic disparity explains the spread between health-care spending in Manitoba and Saskatchewan.
  • Data on the current state of hospital crowding, waiting lists, delays and denials of medical procedures do not yet indicate a significant increase in health-care outcomes, despite significantly higher spending levels.

Source: Public Sector Health Expenditure, by Province/Territory, Health Care in Canada 2003, Canadian Institute for Health Information“Frontier Charticle“ is a one page graphical discussion of regional public policy issues. The Frontier Centre for Public Policy is an independent public policy think tank whose mission is to explore options for the future by undertaking research and education that supports economic growth and opportunity. Contact information, office address, or to add or remove fax numbers and e-mail addresses: 203 – 2727 Portage Avenue * Winnipeg, Manitoba CANADA R3J 0R2*Tel: (204) 957-1567 Fax: (204) 957-1570 * E-mail: newideas@fcpp.org * Website: www.fcpp.org

Read in PDF format here.

Featured News

MORE NEWS

Undue Censorship Still Skews COVID Treatments

Undue Censorship Still Skews COVID Treatments

The censorship and institutional capture evident in the pandemic should be an ongoing concern for policy-makers, scientists, and the medical field. Someone who encountered this first-hand was clinical trials researcher Sabine Hazan, who testified to the National...